InnovaRx Innova Health Strategies

F15.980

Other stimulant use, unspecified with stimulant-induced anxiety disorder

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 3 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 4 never code together
F15code
Excludes2
  • cocaine-related disorders (F14.-)F14.-
F15.9code
Excludes1
  • other stimulant abuse (F15.1-)F15.1-
  • other stimulant dependence (F15.2-)F15.2-
F01-F99chapter
Excludes2
  • symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)R00-R99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 5
F15code
Includes
  • amphetamine-related disorders
  • caffeine
Inclusion terms
  • Amphetamine or other stimulant-induced anxiety disorder, without use disorder
  • Caffeine induced anxiety disorder, without use disorder
F01-F99chapter
Includes
  • disorders of psychological development
Index entries leading here 4
  • Disorder (of) — see also Disease
  • Amphetamine (or other stimulant) -induced
  • Caffeine-induced
  • Use (of)
Alongside this code 3 same parent — F15.98
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC55 CMS28HCC137 ESRD21HCC55 ESRD24HCC55

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
F15.98
Block
F10-F19
Siblings
3

Present FY2024–FY2027.